U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219303) titled 'Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer' on Sept. 16.
Brief Summary: The goal of this clinical trial is to evaluate if adaptive stereotactic body radiation therapy (SBRT) is a safe and effective way to treat prostate cancer in adults. It will assess the safety profile of adaptive SBRT over time.
The main questions this trial aims to answer are:
* What is highest dose of adaptive SBRT without causing serious side effects?
* Can adaptive SBRT more precisely targeting the prostate while reducing radiation exposure to nearby organs?
* What side effects do participants experience during trea...